‘Usually everybody loves money’: Trump’s FDA chief to start giving bonuses for faster drug reviews
The U.S. Food and Drug Administration is adopting a strategy long used in the private sector to increase productivity: paying employees to move faster. FDA Commissioner Marty Makary announced last week that the federal agency will begin offering performance-based cash bonuses to staff who complete drug reviews ahead of schedule. The pilot program, dubbed the…
